(-)-epigallocatechin 3-gallate multiple interactions ISO MYLIP (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MYLIP mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression ISO Mylip (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MYLIP mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Mylip (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYLIP mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO MYLIP (Homo sapiens) 6480464 Estradiol results in decreased expression of MYLIP mRNA CTD PMID:19167446 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO MYLIP (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of MYLIP mRNA CTD PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MYLIP mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MYLIP mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Mylip (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MYLIP mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MYLIP mRNA CTD PMID:22298810 and PMID:34747641 2-hydroxypropanoic acid increases expression ISO MYLIP (Homo sapiens) 6480464 Lactic Acid results in increased expression of MYLIP mRNA CTD PMID:30851411 2-methylcholine affects expression ISO MYLIP (Homo sapiens) 6480464 beta-methylcholine affects the expression of MYLIP mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Mylip (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of MYLIP mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression ISO Mylip (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of MYLIP mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO Mylip (Mus musculus) 6480464 bisphenol S results in increased expression of MYLIP mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO Mylip (Mus musculus) 6480464 bisphenol S affects the methylation of MYLIP gene CTD PMID:31683443 5-fluorouracil affects expression ISO MYLIP (Homo sapiens) 6480464 Fluorouracil affects the expression of MYLIP mRNA CTD PMID:16584549 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MYLIP mRNA CTD PMID:30047161 8-Br-cAMP decreases expression ISO MYLIP (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYLIP mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of MYLIP mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MYLIP mRNA CTD PMID:28959563 acrylamide increases expression ISO MYLIP (Homo sapiens) 6480464 Acrylamide results in increased expression of MYLIP mRNA CTD PMID:32763439 afimoxifene decreases expression ISO MYLIP (Homo sapiens) 6480464 afimoxifene results in decreased expression of MYLIP mRNA CTD PMID:16849584 aflatoxin B1 decreases methylation ISO MYLIP (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of MYLIP gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO MYLIP (Homo sapiens) 6480464 Tretinoin results in increased expression of MYLIP mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of MYLIP mRNA CTD PMID:20488242 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein CTD PMID:34896426 Archazolid B decreases expression ISO MYLIP (Homo sapiens) 6480464 archazolid B results in decreased expression of MYLIP mRNA CTD PMID:25218289 aristolochic acid A increases expression ISO MYLIP (Homo sapiens) 6480464 aristolochic acid I results in increased expression of MYLIP mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Mylip (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of MYLIP mRNA CTD PMID:25270620 arsane decreases response to substance ISO MYLIP (Homo sapiens) 6480464 MYLIP mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 arsenic atom decreases response to substance ISO MYLIP (Homo sapiens) 6480464 MYLIP mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 atrazine increases expression ISO MYLIP (Homo sapiens) 6480464 Atrazine results in increased expression of MYLIP mRNA CTD PMID:22378314 belinostat increases expression ISO MYLIP (Homo sapiens) 6480464 belinostat results in increased expression of MYLIP mRNA CTD PMID:26272509 belinostat multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA CTD PMID:27188386 benzo[a]pyrene increases expression ISO MYLIP (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MYLIP mRNA CTD PMID:20064835 more ... benzo[a]pyrene increases methylation ISO MYLIP (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of MYLIP promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Mylip (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MYLIP mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO MYLIP (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO MYLIP (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 beta-hexachlorocyclohexane decreases expression ISO Mylip (Mus musculus) 6480464 beta-hexachlorocyclohexane results in decreased expression of MYLIP mRNA CTD PMID:25270620 bis(2-ethylhexyl) phthalate decreases expression ISO MYLIP (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of MYLIP mRNA CTD PMID:37536456 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MYLIP mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MYLIP mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A increases expression ISO Mylip (Mus musculus) 6480464 bisphenol A results in increased expression of MYLIP mRNA CTD PMID:30951980 and PMID:34585602 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MYLIP gene CTD PMID:28505145 bisphenol F increases expression ISO Mylip (Mus musculus) 6480464 bisphenol F results in increased expression of MYLIP mRNA CTD PMID:30951980 cadmium atom increases expression ISO MYLIP (Homo sapiens) 6480464 Cadmium results in increased expression of MYLIP mRNA CTD PMID:21120746 calcitriol decreases expression ISO MYLIP (Homo sapiens) 6480464 Calcitriol results in decreased expression of MYLIP mRNA CTD PMID:16002434 carbon nanotube affects expression ISO Mylip (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of MYLIP mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Mylip (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube decreases expression ISO Mylip (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of MYLIP mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO MYLIP (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MYLIP gene] CTD PMID:28238834 chloropicrin increases expression ISO MYLIP (Homo sapiens) 6480464 chloropicrin results in increased expression of MYLIP mRNA CTD PMID:26352163 chromium(6+) increases expression ISO MYLIP (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of MYLIP mRNA CTD PMID:30690063 ciguatoxin CTX1B affects expression ISO Mylip (Mus musculus) 6480464 Ciguatoxins affects the expression of MYLIP mRNA CTD PMID:18353800 copper atom multiple interactions ISO MYLIP (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA and [NSC 689534 binds to Copper] which results in increased expression of MYLIP mRNA CTD PMID:20971185 and PMID:24690739 copper(0) multiple interactions ISO MYLIP (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA and [NSC 689534 binds to Copper] which results in increased expression of MYLIP mRNA CTD PMID:20971185 and PMID:24690739 copper(II) sulfate increases expression ISO MYLIP (Homo sapiens) 6480464 Copper Sulfate results in increased expression of MYLIP mRNA CTD PMID:19549813 coumestrol decreases expression ISO MYLIP (Homo sapiens) 6480464 Coumestrol results in decreased expression of MYLIP mRNA CTD PMID:19167446 coumestrol multiple interactions ISO MYLIP (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA CTD PMID:19167446 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of MYLIP mRNA CTD PMID:26577399 cyclosporin A increases expression ISO MYLIP (Homo sapiens) 6480464 Cyclosporine results in increased expression of MYLIP mRNA CTD PMID:25562108 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein CTD PMID:34896426 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein CTD PMID:34896426 cytarabine decreases expression ISO MYLIP (Homo sapiens) 6480464 Cytarabine results in decreased expression of MYLIP mRNA CTD PMID:21198554 disulfiram multiple interactions ISO MYLIP (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO Mylip (Mus musculus) 6480464 Doxorubicin results in increased expression of MYLIP mRNA CTD PMID:25896364 doxorubicin increases expression ISO MYLIP (Homo sapiens) 6480464 Doxorubicin results in increased expression of MYLIP mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MYLIP mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO MYLIP (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA CTD PMID:19167446 entinostat increases expression ISO MYLIP (Homo sapiens) 6480464 entinostat results in increased expression of MYLIP mRNA CTD PMID:26272509 entinostat multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO MYLIP (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of MYLIP mRNA CTD PMID:23649840 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein CTD PMID:34896426 folic acid multiple interactions ISO Mylip (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYLIP mRNA CTD PMID:22206623 folic acid decreases expression ISO Mylip (Mus musculus) 6480464 Folic Acid results in decreased expression of MYLIP mRNA CTD PMID:25629700 formaldehyde increases expression ISO MYLIP (Homo sapiens) 6480464 Formaldehyde results in increased expression of MYLIP mRNA CTD PMID:20655997 and PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of MYLIP mRNA CTD PMID:27387713 genistein increases expression ISO MYLIP (Homo sapiens) 6480464 Genistein results in increased expression of MYLIP mRNA CTD PMID:18847459 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MYLIP mRNA CTD PMID:22061828 glyphosate decreases expression ISO Mylip (Mus musculus) 6480464 Glyphosate results in decreased expression of MYLIP mRNA CTD PMID:35897073 GW 3965 increases expression ISO MYLIP (Homo sapiens) 6480464 GW 3965 results in increased expression of MYLIP mRNA CTD PMID:27598782 GW 4064 decreases expression ISO MYLIP (Homo sapiens) 6480464 GW 4064 results in decreased expression of MYLIP mRNA CTD PMID:31437187 Heptachlor epoxide decreases expression ISO Mylip (Mus musculus) 6480464 Heptachlor Epoxide results in decreased expression of MYLIP mRNA CTD PMID:25270620 hydroquinone decreases expression ISO MYLIP (Homo sapiens) 6480464 hydroquinone results in decreased expression of MYLIP mRNA CTD PMID:31256213 isoprenaline increases expression ISO Mylip (Mus musculus) 6480464 Isoproterenol results in increased expression of MYLIP mRNA CTD PMID:20003209 lead(0) affects expression ISO MYLIP (Homo sapiens) 6480464 Lead affects the expression of MYLIP mRNA CTD PMID:22313790 and PMID:28903495 Licochalcone B increases expression ISO MYLIP (Homo sapiens) 6480464 licochalcone B results in increased expression of MYLIP mRNA CTD PMID:33647349 maneb multiple interactions ISO Mylip (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of MYLIP mRNA CTD PMID:36117858 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of MYLIP mRNA CTD PMID:30047161 methyl methanesulfonate increases expression ISO MYLIP (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of MYLIP mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO MYLIP (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of MYLIP mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO MYLIP (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of MYLIP mRNA CTD PMID:28001369 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of MYLIP mRNA CTD PMID:25972201 mitomycin C affects response to substance ISO MYLIP (Homo sapiens) 6480464 MYLIP protein affects the susceptibility to Mitomycin CTD PMID:16217747 nickel sulfate increases expression ISO MYLIP (Homo sapiens) 6480464 nickel sulfate results in increased expression of MYLIP mRNA CTD PMID:22714537 ozone multiple interactions ISO Mylip (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MYLIP mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO MYLIP (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of MYLIP mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA CTD PMID:27188386 panobinostat multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA CTD PMID:27188386 panobinostat increases expression ISO MYLIP (Homo sapiens) 6480464 panobinostat results in increased expression of MYLIP mRNA CTD PMID:26272509 paracetamol increases expression ISO MYLIP (Homo sapiens) 6480464 Acetaminophen results in increased expression of MYLIP mRNA CTD PMID:21420995 and PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MYLIP mRNA CTD PMID:33387578 paraquat multiple interactions ISO Mylip (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of MYLIP mRNA CTD PMID:36117858 phenobarbital decreases expression ISO Mylip (Mus musculus) 6480464 Phenobarbital results in decreased expression of MYLIP mRNA CTD PMID:19482888 phenobarbital affects expression ISO Mylip (Mus musculus) 6480464 Phenobarbital affects the expression of MYLIP mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO Mylip (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MYLIP mRNA] CTD PMID:19482888 potassium chromate multiple interactions ISO MYLIP (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MYLIP mRNA CTD PMID:22079256 potassium chromate increases expression ISO MYLIP (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of MYLIP mRNA CTD PMID:22079256 and PMID:22714537 progesterone increases expression ISO MYLIP (Homo sapiens) 6480464 Progesterone results in increased expression of MYLIP mRNA CTD PMID:18037150 progesterone decreases expression ISO MYLIP (Homo sapiens) 6480464 Progesterone results in decreased expression of MYLIP mRNA CTD PMID:21795739 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of MYLIP protein CTD PMID:34896426 quercetin increases expression ISO MYLIP (Homo sapiens) 6480464 Quercetin results in increased expression of MYLIP mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO MYLIP (Homo sapiens) 6480464 Lactic Acid results in increased expression of MYLIP mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium dichromate increases expression ISO MYLIP (Homo sapiens) 6480464 sodium bichromate results in increased expression of MYLIP mRNA CTD PMID:17685462 Soman increases expression EXP 6480464 Soman results in increased expression of MYLIP mRNA CTD PMID:19281266 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of MYLIP mRNA CTD PMID:30047161 sunitinib increases expression ISO MYLIP (Homo sapiens) 6480464 Sunitinib results in increased expression of MYLIP mRNA CTD PMID:31533062 temozolomide increases expression ISO MYLIP (Homo sapiens) 6480464 Temozolomide results in increased expression of MYLIP mRNA CTD PMID:31758290 testosterone increases expression ISO Mylip (Mus musculus) 6480464 Testosterone deficiency results in increased expression of MYLIP mRNA CTD PMID:33848595 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MYLIP mRNA CTD PMID:34492290 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of MYLIP gene CTD PMID:27618143 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of MYLIP mRNA CTD PMID:33387578 trichostatin A increases expression ISO MYLIP (Homo sapiens) 6480464 trichostatin A results in increased expression of MYLIP mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA CTD PMID:27188386 triclosan increases expression ISO MYLIP (Homo sapiens) 6480464 Triclosan results in increased expression of MYLIP mRNA CTD PMID:30510588 triptonide increases expression ISO Mylip (Mus musculus) 6480464 triptonide results in increased expression of MYLIP mRNA CTD PMID:33045310 tunicamycin decreases expression ISO MYLIP (Homo sapiens) 6480464 Tunicamycin results in decreased expression of MYLIP mRNA CTD PMID:22378314 urethane increases expression ISO MYLIP (Homo sapiens) 6480464 Urethane results in increased expression of MYLIP mRNA CTD PMID:28818685 valproic acid affects expression ISO Mylip (Mus musculus) 6480464 Valproic Acid affects the expression of MYLIP mRNA CTD PMID:17292431 valproic acid multiple interactions ISO MYLIP (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA CTD PMID:27188386 valproic acid increases expression ISO MYLIP (Homo sapiens) 6480464 Valproic Acid results in increased expression of MYLIP mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO MYLIP (Homo sapiens) 6480464 Valproic Acid affects the expression of MYLIP mRNA CTD PMID:25979313 valproic acid increases expression ISO Mylip (Mus musculus) 6480464 Valproic Acid results in increased expression of MYLIP mRNA CTD PMID:19136453 and PMID:21427059 zinc atom multiple interactions ISO MYLIP (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MYLIP mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO MYLIP (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MYLIP mRNA CTD PMID:18593933